Zobrazeno 1 - 10 of 78 pro vyhledávání: '"J Peter Cegielski"'
1
Akademický článek
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.
Autor: Courtney M Yuen, Ekaterina V Kurbatova, Thelma Tupasi, Janice Campos Caoili, Martie Van Der Walt, Charlotte Kvasnovsky, Martin Yagui, Jaime Bayona, Carmen Contreras, Vaira Leimane, Julia Ershova, Laura E Via, HeeJin Kim, Somsak Akksilp, Boris Y Kazennyy, Grigory V Volchenkov, Ruwen Jou, Kai Kliiman, Olga V Demikhova, Irina A Vasilyeva, Tracy Dalton, J Peter Cegielski
Publikováno v: PLoS Medicine, Vol 12, Iss 12, p e1001932 (2015)
BackgroundFor treating multidrug-resistant tuberculosis (MDR TB), the World Health Organization (WHO) recommends a regimen of at least four second-line drugs that are likely to be effective as well as pyrazinamide. WHO guidelines indicate only margin
Externí odkaz: https://doaj.org/article/ace629e2383f4a7b89c77c4a3526dd6b
Zobrazit plný text záznamu
2
Akademický článek
Association between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistance.
Autor: Courtney M Yuen, Ekaterina V Kurbatova, Eleanor S Click, J Sean Cavanaugh, J Peter Cegielski
Publikováno v: PLoS ONE, Vol 8, Iss 12, p e83006 (2013)
BackgroundDevelopment of resistance to antituberculosis drugs during treatment (i.e., acquired resistance) can lead to emergence of resistant strains and consequent poor clinical outcomes. However, it is unknown whether Mycobacterium tuberculosis com
Externí odkaz: https://doaj.org/article/1a22faf0fe904398981757d91e3d2731
Zobrazit plný text záznamu
3
Akademický článek
Prevalence of anti-tuberculosis drug resistance in foreign-born tuberculosis cases in the U.S. and in their countries of origin.
Autor: Allison B Taylor, Ekaterina V Kurbatova, J Peter Cegielski
Publikováno v: PLoS ONE, Vol 7, Iss 11, p e49355 (2012)
BACKGROUND: Foreign-born individuals comprise >50% of tuberculosis (TB) cases in the U.S. Since anti-TB drug resistance is more common in most other countries, when evaluating a foreign-born individual for TB, one must consider the risk of drug resis
Externí odkaz: https://doaj.org/article/564b8f198054466cbe2785718d21e88a
Zobrazit plný text záznamu
6
A University-Led Contact Tracing Program Response to a COVID-19 Outbreak Among Students in Georgia, February-March 2021
Autor: Kristin R.V. Harrington, Meron R. Siira, Elizabeth P. Rothschild, Sharon R. Rabinovitz, Samuel Shartar, David Clark, Alexander Isakov, Allison Chamberlain, Enku Gelaye, J. Peter Cegielski, Neel R. Gandhi
Publikováno v: Public health reports (Washington, D.C. : 1974). 137(2_suppl)
Few reports have described how university programs have controlled COVID-19 outbreaks. Emory University established a case investigation and contact tracing program in June 2020 to identify and mitigate transmission of SARS-CoV-2 in the Emory communi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01b45615da20e1f40bca12190b20dc6
https://pubmed.ncbi.nlm.nih.gov/35989589
Zobrazit plný text záznamu
7
Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009–2016
Autor: Zarir F Udwadia, Pei-Chun Chan, Piret Viiklepp, Dick Menzies, Zhiyi Lan, Jae-Joon Yim, J. Peter Cegielski
Publikováno v: Clin Infect Dis
Background As new drugs are developed for multidrug-resistant tuberculosis (MDR-TB), the role of currently used drugs must be reevaluated. Methods We combined individual-level data on patients with pulmonary MDR-TB published during 2009–2016 from 2
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::611b4c9d501ddbe77407fef413103891
https://doi.org/10.1093/cid/ciaa621
Zobrazit plný text záznamu
9
Evidence-based Definition for Extensively Drug-resistant Tuberculosis
Autor: Lorenzo Guglielmetti, Mario Carlo Raviglione, Liudmila Rozanova, Jonathon R. Campbell, Didi Bang, Maroussia Roelens, Christoph Lange, Giovanni Battista Migliori, Janne Estill, Simon Tiberi, Olivia Keiser, Dick Menzies, J. Peter Cegielski, James C.M. Brust, Greg J. Fox, Domingo Palmero, Giovanni Sotgiu, Christian Lienhardt
Publikováno v: American Journal of Respiratory and Critical Care Medicine, Vol. 204, No 6 (2021) pp. 713-722
Rationale: Until 2020, extensively drug-resistant tuberculosis (XDR-TB) was defined as resistance to rifampicin and isoniazid (multidrug-resistant tuberculosis, MDR-TB), any fluoroquinolone (FQ) and any second-line injectable drug (SLID). In 2019 the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6c8623d07b60fcbf29c1eaebffe7e4
https://archive-ouverte.unige.ch/unige:155191
Zobrazit plný text záznamu
10
Antimicrobial drug resistance and infection prevention/control: lessons from tuberculosis
Autor: Paul A. Jensen, Carrie Tudor, Grigory V. Volchenkov, J. Peter Cegielski
Publikováno v: International Journal of Infection Control.
Antimicrobial drug resistance (AMR) is increasing rapidly worldwide, causing an estimated 700,000 deaths annually over the past decade, en route to becoming the leading global threat to public health by 2050 with an estimated 10 million deaths per ye
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::60982e833014e870292d0a355915cf6d
https://doi.org/10.3396/ijic.v17.20840
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje